CBD in AB InBev's future | Brazcann

Alcoholic beverages

CBD on AB InBev's horizon: a new category of functional beverages

AB InBev could turn its cannabis research into a global alcohol-free line with CBD. Scale AB InBev's learning in cannabinoid beverages (from its research joint venture with Tilray) into a global alcohol-free line with CBD. Below, an independent strategic analysis by Brazcann on how this would be possible — and what the brand stands to gain.

If you're looking for «AB InBev hemp», «AB InBev and cannabis» or a cannabis beverage linked to AB InBev, this report brings together the science, the potential of industrial cannabis and the business path behind the idea.

AB InBev's current challenge

AB InBev, the world's largest brewer, has already signed a research joint venture with Tilray for alcohol-free cannabinoid beverages, a sign of its bet on the category. Turning that learning into a global product as regulation allows is the challenge.

The science behind: cannabinoids and electrolytes

Cannabidiol (CBD) is a non-psychoactive cannabinoid studied for anxiolytic and anti-inflammatory effects. Worldwide there is already a market for CBD beverages (Lagunitas, part of the Heineken group, launched Hi-Fi Hops). Combined with electrolytes (sodium, potassium, magnesium) for hydration, the concept targets wellness and recovery. It is a space that demands regulatory rigor: the sale of cannabinoid beverages is restricted and varies by country.

CBD: a non-psychoactive cannabinoid, without THC's "euphoria" effect.
Electrolytes replenish mineral salts lost through hydration.
A growing wellness/functional category abroad.
An adult, premium positioning, distinct from a regular soft drink.

How AB InBev would apply cannabinoids and electrolytes

AB InBev could convert its research into an alcohol-free line with CBD, distributed by the largest brewing network on the planet, positioned for the audience cutting back on alcohol.

A possible path

Capitalize on the learning from the research joint venture with Tilray.
Formulate an alcohol-free line with CBD ready to scale.
Distribute it by market as cannabinoid regulation evolves.

The potential gain (hypothetical scenario)

In a hypothetical scenario, AB InBev would convert its pioneering research into a global alcohol-free line with CBD, leveraged by the largest brewing distribution — dependent on regulation.

Sustainability: Bets on plant-based ingredients and a wellness positioning, aligned with conscious-consumption trends.

The link with Brazil and Brazcann

In Brazil, products with cannabinoids are regulated by Anvisa (RDC 660/2022 and the new framework RDC 1,015/2026); a free-sale CBD beverage is not yet permitted — so the scenario is strategic/forward-looking, dependent on regulatory evolution.

Brazcann operates precisely at this bridge: regulatory intelligence, importing and structuring cannabis and hemp businesses in Brazil — helping companies turn scenarios like this into viable, Anvisa-compliant projects.

Frequently asked questions

Does AB InBev already research cannabis?

Yes: it signed a research joint venture with Tilray to study alcohol-free cannabinoid beverages.

Would it be a beer with marijuana?

No: the proposal is an alcohol-free drink with CBD, non-psychoactive — nothing to do with THC's effect.

Is there a marijuana beverage?

The popular term is "marijuana", but the correct material here is industrial hemp — Cannabis sativa with THC ≤ 0.3%, with no psychoactive effect. It is the source of cannabinoids and electrolytes in this analysis. It is not a drug, but a renewable, sustainable industrial material.